Tag: biomedical
-
Moderna Funding University Immunology Research
A biotechnology enterprise is financing a collaboration with Harvard Medical School that aims to discover new mechanisms for treating immune system disorders.
-
Synthetic Biology Platform Designed for Vaccines
Researchers in France and the U.K. developed a modular technology with synthetic and computational biology for designing vaccines against infectious diseases.
-
23andMe, TrialSpark Partner on Clinical Trial Recruiting
A new collaboration of a genetics testing company with a clinical study site contractor aims to broaden and speed-up enrolling individuals in clinical trials.
-
Stem Cells Grow New Spinal Disc Tissue
Tests with lab animals show stem cells derived from human donors can generate new spinal disc cells and tissue to help treat degenerating discs.
-
Review – Deep Learning As Good As Live Expert Diagnostics
A review of recent research shows — with caveats — deep learning algorithms appear as effective as live human experts in accurately interpreting medical images.
-
Cannabis Epilepsy Treatment Approved in Europe
The European Commission yesterday endorsed a recommendation to market in Europe a cannabis-based treatment for seizures from two rare forms of epilepsy.
-
FDA Releases Guidance on ALS Therapies
The Food and Drug Administration issued its latest guidance to developers of new drugs and biologics for treating amyotrophic lateral sclerosis, or ALS.
-
Biotech Developing Genome-Adjusting Disease Treatments
A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins.
-
Trial Underway Testing Brain-Computer Implant
The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain signals, testing the implant’s feasibility for assistive technology.
-
Opioid Abuse Treatment Medications Underused
While three medications for opioid abuse are approved by the Food and Drug Administration, the treatments are used sparingly in therapy according to a new review of data.